These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

334 related articles for article (PubMed ID: 32486848)

  • 1. Histone deacetylase-3: Friend and foe of the brain.
    D'Mello SR
    Exp Biol Med (Maywood); 2020 Jul; 245(13):1130-1141. PubMed ID: 32486848
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone deacetylase 3 inhibitors in learning and memory processes with special emphasis on benzamides.
    Amin SA; Adhikari N; Kotagiri S; Jha T; Ghosh B
    Eur J Med Chem; 2019 Mar; 166():369-380. PubMed ID: 30735902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A role for histone deacetylases in the cellular and behavioral mechanisms underlying learning and memory.
    Mahgoub M; Monteggia LM
    Learn Mem; 2014 Oct; 21(10):564-8. PubMed ID: 25227251
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the correct HDAC(s) to treat cognitive disorders.
    Fischer A; Sananbenesi F; Mungenast A; Tsai LH
    Trends Pharmacol Sci; 2010 Dec; 31(12):605-17. PubMed ID: 20980063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone Deacetylase (HDAC) Inhibitors - emerging roles in neuronal memory, learning, synaptic plasticity and neural regeneration.
    Ganai SA; Ramadoss M; Mahadevan V
    Curr Neuropharmacol; 2016; 14(1):55-71. PubMed ID: 26487502
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proteomic analysis identifies NPTX1 and HIP1R as potential targets of histone deacetylase-3-mediated neurodegeneration.
    Qu Z; D'Mello SR
    Exp Biol Med (Maywood); 2018 Apr; 243(7):627-638. PubMed ID: 29486577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylase 3 (HDAC3) inhibitors as anticancer agents: A review.
    Sarkar R; Banerjee S; Amin SA; Adhikari N; Jha T
    Eur J Med Chem; 2020 Apr; 192():112171. PubMed ID: 32163814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modulating epigenetic HAT activity for reinstating acetylation homeostasis: A promising therapeutic strategy for neurological disorders.
    Ganai SA; Banday S; Farooq Z; Altaf M
    Pharmacol Ther; 2016 Oct; 166():106-22. PubMed ID: 27411674
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dissecting Histone Deacetylase 3 in Multiple Disease Conditions: Selective Inhibition as a Promising Therapeutic Strategy.
    Adhikari N; Jha T; Ghosh B
    J Med Chem; 2021 Jul; 64(13):8827-8869. PubMed ID: 34161101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase in neuropathology.
    Gupta R; Ambasta RK; Kumar P
    Adv Clin Chem; 2021; 104():151-231. PubMed ID: 34462055
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Context and Auditory Fear are Differentially Regulated by HDAC3 Activity in the Lateral and Basal Subnuclei of the Amygdala.
    Kwapis JL; Alaghband Y; López AJ; White AO; Campbell RR; Dang RT; Rhee D; Tran AV; Carl AE; Matheos DP; Wood MA
    Neuropsychopharmacology; 2017 May; 42(6):1284-1294. PubMed ID: 27924874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human neuronal cells: epigenetic aspects.
    Kukucka J; Wyllie T; Read J; Mahoney L; Suphioglu C
    Biomol Concepts; 2013 Aug; 4(4):319-33. PubMed ID: 25436583
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic histone acetylation and deacetylation mechanisms in experimental models of neurodegenerative disorders.
    Konsoula Z; Barile FA
    J Pharmacol Toxicol Methods; 2012; 66(3):215-20. PubMed ID: 22902970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Therapeutic potential of selective histone deacetylase 3 inhibition.
    Zhang L; Chen Y; Jiang Q; Song W; Zhang L
    Eur J Med Chem; 2019 Jan; 162():534-542. PubMed ID: 30472601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Memory Specific to Temporal Features of Sound Is Formed by Cue-Selective Enhancements in Temporal Coding Enabled by Inhibition of an Epigenetic Regulator.
    Rotondo EK; Bieszczad KM
    J Neurosci; 2021 Nov; 41(44):9192-9209. PubMed ID: 34544835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Histone Deacetylase Inhibitors as Cognitive Enhancers and Modifiers of Mood and Behavior.
    Pal D; Sahu P; Mishra AK; Hagelgans A; Sukocheva O
    Curr Drug Targets; 2023; 24(9):728-750. PubMed ID: 36475351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Histone deacetylase 3 inhibition re-establishes synaptic tagging and capture in aging through the activation of nuclear factor kappa B.
    Sharma M; Shetty MS; Arumugam TV; Sajikumar S
    Sci Rep; 2015 Nov; 5():16616. PubMed ID: 26577291
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The critical roles of histone deacetylase 3 in the pathogenesis of solid organ injury.
    Ning L; Rui X; Bo W; Qing G
    Cell Death Dis; 2021 Jul; 12(8):734. PubMed ID: 34301918
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR screen identifies the NCOR/HDAC3 complex as a major suppressor of differentiation in rhabdomyosarcoma.
    Phelps MP; Bailey JN; Vleeshouwer-Neumann T; Chen EY
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):15090-15095. PubMed ID: 27956629
    [TBL] [Abstract][Full Text] [Related]  

  • 20. HDAC2 negatively regulates memory formation and synaptic plasticity.
    Guan JS; Haggarty SJ; Giacometti E; Dannenberg JH; Joseph N; Gao J; Nieland TJ; Zhou Y; Wang X; Mazitschek R; Bradner JE; DePinho RA; Jaenisch R; Tsai LH
    Nature; 2009 May; 459(7243):55-60. PubMed ID: 19424149
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.